Search by Drug Name or NDC

    NDC 70539-0001-98 Tymlos 3.12 mg/1.56mL Details

    Tymlos 3.12 mg/1.56mL

    Tymlos is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Radius Health, Inc.. The primary component is ABALOPARATIDE.

    Product Information

    NDC 70539-0001
    Product ID 70539-001_5c342488-a83e-4581-b45c-9261285c39d8
    Associated GPIs 3004400500D230
    GCN Sequence Number 077351
    GCN Sequence Number Description abaloparatide PEN INJCTR 80MCG/DOSE SUBCUT
    HIC3 P4F
    HIC3 Description BONE FORMATION STIMULATING AGTS - PTH REL PEPTIDES
    GCN 43334
    HICL Sequence Number 044231
    HICL Sequence Number Description ABALOPARATIDE
    Brand/Generic Brand
    Proprietary Name Tymlos
    Proprietary Name Suffix n/a
    Non-Proprietary Name abaloparatide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 3.12
    Active Ingredient Units mg/1.56mL
    Substance Name ABALOPARATIDE
    Labeler Name Radius Health, Inc.
    Pharmaceutical Class Parathyroid Hormone-Related Peptide Analog [EPC], Parathyroid Hormone-Related Protein [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA208743
    Listing Certified Through 2024-12-31

    Package

    NDC 70539-0001-98 (70539000198)

    NDC Package Code 70539-001-98
    Billing NDC 70539000198
    Package 1 CARTRIDGE in 1 BOX, UNIT-DOSE (70539-001-98) / 1.56 mL in 1 CARTRIDGE (70539-001-99)
    Marketing Start Date 2017-05-01
    NDC Exclude Flag N
    Pricing Information N/A